OVERVIEW

2nd Annual Clinical Trials Asia is organized by IBC - an Informa Business and Would be held during Aug 3 - 5, 2016 at Suntec Singapore International Convention and Exhibition Centre, Singapore. The targeted audience for this medical event basically for pharma and biotech,government and regulators,medical device and diagnotics, labs, technology and solution providers.

This event focuses on best practices in clinical trial project management and clinical research excellence for the Asian region. Learn how to smoothly integrate Asia Pacific into global clinical trials with a focus on enhancing trial quality, improved research outcomes and accelerated timelines for drug approvals."Asia Pacific continues to be an important region for the conduct of clinical tri­als. With multiple initiatives underway at both local and regional levels aimed at improving the conduct of studies, it is expected that this trend will continue."

IBC’s 2nd Annual Clinical Trials Asia zeroes in on the key operational and executional challenges in the burgeoning trial markets within Asia Pacific. Clinical Trials Asia 2016 will focus on how Asia Pacific can improve quality in global clinical programmes in Asia and how Asia Pacific smoothly integrate into global clinical programmes. The programme will also explore how mid-size to smaller companies can strategize to devise a pathway for launching products outside Asia.

KEY DATES

Event Start Date
03 Aug, 2016
Event Start Date
Event End Date
05 Aug, 2016
Event End Date

SPECIALITIES

Clinical PharmacologyResearch and Clinical Research

SUGGESTED HOTELS

CONFERENCE VENUE

LocationSuntec Singapore International Convention and Exhibition Centre
1 Raffles Boulevard, Suntec City

RELATED CONFERENCES & LIVE WEBINARS

icons

Aug 21, 2026 | Washington, Dist...

State required course for Illinois ...
14 CE/CME
More actions
US$995

Jul 23 - 24, 2026 | Vienna, Wien, AT

Research and Clinical Research
More actions
AT€350

Nov 12 - 14, 2026 | Orlando, Florida, USA

State required course for Illinois ...
37 CME/CE
More actions
US$2,295